915107-31-2

Usage

Uses

Used in Pharmaceutical Industry:
6-Chloro-5-methoxy-nicotinic acid methyl ester is used as a potential therapeutic agent for its anti-inflammatory, anti-cancer, and anti-viral activities. Its pharmacological properties make it a promising candidate for the development of new drugs to treat various diseases.
Used in Research Industry:
In the research field, 6-Chloro-5-methoxy-nicotinic acid methyl ester is utilized for studying its pharmacological properties and potential applications in drug discovery. Its derivatives are being investigated for their potential as drug candidates, contributing to the advancement of medicinal chemistry.
Used in Organic Synthesis:
6-Chloro-5-methoxy-nicotinic acid methyl ester is also employed in organic synthesis, where it serves as a key intermediate or building block for the synthesis of more complex organic compounds. Its unique structure and functional groups make it a versatile component in the creation of novel molecules with potential applications in various industries.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 6-Chloro-5-methoxy-nicotinic acid methyl ester is used for the design and synthesis of new pharmaceutical agents. Its structural features and biological activities provide a foundation for the development of innovative drugs with improved efficacy and selectivity for various therapeutic targets.

Upstream product

• 30766-22-4 methyl 5-hydroxy-3-pyridinecarboxylate 
• 915107-30-1 methyl 6-chloro-5-hydroxypyridine-3-carboxylate 
• 74-88-4 methyl iodide 

Downstream Products

• 915107-39-0 6-chloro-5-methoxynicotinic acid 
• 380912-09-4 5-hydroxy imidacloprid 
• 915107-47-0 (6-chloro-5-methoxypyridin-3-yl)methanol 

Relevant academic research and scientific papers

Synthesis method of imidacloprid metabolite 5-hydroxyimidacloprid

The invention discloses a synthesis method of an imidacloprid metabolite 5-hydroxyimidacloprid, and belongs to the field of medicine synthesis. According to the synthesis method, methyl 5-hydroxynicotinate is used as a raw material, synthesis of the imidacloprid metabolite 5-hydroxylimidacloprid is achieved for the first time through six-step reaction, an optimal synthesis route and reaction conditions are screened out through a large number of experiments, the purity of the prepared target product can reach 99% or above, and the target product does not contain raw material medicine imidacloprid can be used for research on pharmacokinetics, raw material medicine impurity identification, environment control and protection and the like, provides a sample for impurity identification of imidacloprid, metabolic mechanism research, influence on the environment after medicine use, how to carry out corresponding protection and the like, and has important application value.

TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.

NOVEL HETEROARYL IMIDAZOLES AND HETEROARYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I; (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 065

The invention provides compounds of formula wherein R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066

The invention provides compounds of formula wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

Multi-substituted pyridyl sulfoximines and their use as insecticides

Multi-substituted pyridyl sulfoximines are useful as insecticides.